SCHEMBL25189296

SCHEMBL25189296

COC1CCC(Nc2cc(C)nc(-n3nc(C)cc3C)n2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN2 Q9H2S1 1/20 0.73
KCNN3 Q9UGI6 1/20 0.73
ALOX15 P16050 3/20 0.56
LMNA P02545 4/20 0.52
NPSR1 Q6W5P4 3/20 0.52
HIF1A Q16665 1/20 0.52
TP53 P04637 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
MAPK1 P28482 2/20 0.49
TSHR P16473 1/20 0.49
ALDH1A1 P00352 1/20 0.49
POLB P06746 4/20 0.48
MAPT P10636 2/20 0.47
ADORA2A P29274 1/20 0.46
TSPO P30536 1/20 0.46
ADORA1 P30542 1/20 0.46
GPR183 P32249 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
GPR35 Q9HC97 1/20 0.46
HTT P42858 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4207857 0.86 KCNN3 (0.97) KCNN2KCNN3ALOX15LMNANPSR1
SCHEMBL25187421 0.85 KCNN3 (0.77) KCNN2KCNN3ALOX15LMNANPSR1
SCHEMBL30421414 0.85 KCNN3 (0.77) KCNN2KCNN3ALOX15LMNANPSR1
SCHEMBL25191245 0.85 KCNN3 (0.77) KCNN2KCNN3ALOX15LMNANPSR1
SCHEMBL3233745 0.85 KCNN3 (1.00) KCNN2KCNN3ALOX15LMNANPSR1
SCHEMBL29355074 0.85 KCNN3 (1.00) KCNN2KCNN3ALOX15LMNANPSR1
SCHEMBL25203125 0.82 KCNN2 (0.72) KCNN2KCNN3ALOX15LMNANPSR1
SCHEMBL19686804 0.81 KCNN3 (0.73) KCNN2KCNN3ALOX15LMNANPSR1
SCHEMBL21165969 0.80 KCNN2 (0.59) KCNN2KCNN3ALOX15LMNANPSR1
SCHEMBL25188176 0.80 KCNN3 (0.69) KCNN2KCNN3ALOX15LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12312333-B2 SK channel positive allosteric modulators CHAPMAN UNIVERSITY (US) 2025-05-27 US disclosed
US-20230159500-A1 SK CHANNEL POSITIVE ALLOSTERIC MODULATORS CHAPMAN UNIVERSITY 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159500-A1 SK CHANNEL POSITIVE ALLOSTERIC MODULATORS KCNN1, KCNN4, KCNN2 KCNN2 3/4885KCNN3 4/4885ALOX15 3494/4885
US-12312333-B2 SK channel positive allosteric modulators KCNN1, KCNN4, KCNN2 KCNN2 3/4885KCNN3 4/4885ALOX15 3570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.